A pharmaceutical authentication company is now selling equipment which can verify drug ingredients outside of a laboratory. XStream Systems, Inc. offers a unit which can read the molecular structure of medicines without having to open any packaging or break a bottle’s seal.

Named the XT250 System, its underlying technology was originally developed to protect the public from terrorist threats, but has since found its role in the pharmaceutical industry. It can tell if a drug is counterfeit, altered, contaminated, or otherwise different on a molecular level from its intended form.

“This unit is of great benefit when dealing with drugs or ingredients from questionable sources, such as what we’ve seen from China in the recent Heparin incident,” stated John Lundquist, VP of Business Development for XStream Systems. “The fact it can test drugs when they are still in the manufacturer’s packaging makes the system even more valuable to companies trying to keep their outbound shipments clean.”

The XT250 System is currently being used at multiple locations in the pharmaceutical supply network, checking inventories for dangerous products.

XStream Systems, Inc.
XStream Systems produces next-generation equipment for material identification. Their patented systems are based on Energy-Dispersive X-Ray Diffraction (EDXRD) technology. The company’s XT250™ System enables testing of powders, pills AND entire sealed bottles. The equipment’s superior sample penetration allows the identification of contents inside opaque plastic, cardboard and even metal packaging.

For more information, call 1-800-597-1191, visit securepharmachain or securepharmablog online.